Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other financing activities (2018)

X4 Pharmaceuticals (XFOR) has disclosed Other financing activities for 1 consecutive years, with $43000.0 as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Other financing activities changed N/A year-over-year to $43000.0, compared with a TTM value of $43000.0 through Dec 2018, changed N/A, and an annual FY2018 reading of $43000.0, down 96.93% over the prior year.
  • Other financing activities was $43000.0 for Q1 2018 at X4 Pharmaceuticals.
  • Across five years, Other financing activities topped out at $43000.0 in Q1 2018 and bottomed at $43000.0 in Q1 2018.